4//SEC Filing
Maxwell John T. 4
Accession 0001140361-18-033743
CIK 0001398733other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:12 PM ET
Size
5.3 KB
Accession
0001140361-18-033743
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2018-07-24+36,120→ 36,120 totalExercise: $15.00Exp: 2028-07-24→ Common Stock (36,120 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Maxwell's continuous service with the Issuer from the grant date through the applicable vesting date.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001739025
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:12 PM ET
- Size
- 5.3 KB